Annual Total Debt
$4.64 M
-$317.00 K-6.39%
31 December 2023
Summary:
Acrivon Therapeutics Common Stock annual total debt is currently $4.64 million, with the most recent change of -$317.00 thousand (-6.39%) on 31 December 2023. During the last 3 years, it has risen by +$4.59 million (+7906.90%). ACRV annual total debt is now -17.48% below its all-time high of $5.63 million, reached on 31 December 2021.ACRV Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$4.01 M
-$208.00 K-4.93%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock quarterly total debt is currently $4.01 million, with the most recent change of -$208.00 thousand (-4.93%) on 30 September 2024. Over the past year, it has dropped by -$407.00 thousand (-9.21%). ACRV quarterly total debt is now -28.70% below its all-time high of $5.63 million, reached on 01 December 2021.ACRV Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.4% | -9.2% |
| 3 y3 years | +7906.9% | -28.7% |
| 5 y5 years | - | - |
ACRV Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -17.5% | +7906.9% | -28.7% | |
| 5 y | 5 years | -17.5% | +7906.9% | -28.7% | |
| alltime | all time | -17.5% | +7906.9% | -28.7% |
Acrivon Therapeutics Common Stock Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.01 M(-4.9%) |
| June 2024 | - | $4.22 M(-5.0%) |
| Mar 2024 | - | $4.45 M(-4.3%) |
| Dec 2023 | $4.64 M(-6.4%) | $4.64 M(+5.1%) |
| Sept 2023 | - | $4.42 M(-3.9%) |
| June 2023 | - | $4.60 M(-3.9%) |
| Mar 2023 | - | $4.79 M(-3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $4.96 M(-11.9%) | $4.96 M(-3.4%) |
| Sept 2022 | - | $5.14 M(-3.2%) |
| June 2022 | - | $5.31 M(>+9900.0%) |
| Mar 2022 | - | $0.00(-100.0%) |
| Dec 2021 | $5.63 M(+9603.4%) | - |
| Dec 2021 | - | $5.63 M(>+9900.0%) |
| Sept 2021 | - | $0.00 |
| Dec 2020 | $58.00 K | - |
FAQ
- What is Acrivon Therapeutics Common Stock annual total debt?
- What is the all time high annual total debt for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock annual total debt year-on-year change?
- What is Acrivon Therapeutics Common Stock quarterly total debt?
- What is the all time high quarterly total debt for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock quarterly total debt year-on-year change?
What is Acrivon Therapeutics Common Stock annual total debt?
The current annual total debt of ACRV is $4.64 M
What is the all time high annual total debt for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high annual total debt is $5.63 M
What is Acrivon Therapeutics Common Stock annual total debt year-on-year change?
Over the past year, ACRV annual total debt has changed by -$317.00 K (-6.39%)
What is Acrivon Therapeutics Common Stock quarterly total debt?
The current quarterly total debt of ACRV is $4.01 M
What is the all time high quarterly total debt for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high quarterly total debt is $5.63 M
What is Acrivon Therapeutics Common Stock quarterly total debt year-on-year change?
Over the past year, ACRV quarterly total debt has changed by -$407.00 K (-9.21%)